Dandelions Therapeutics Inc
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Dandelions Therapeutics Inc - overview
Location
-, -, US
Primary Industry
Healthcare IT
About
Based in the US, Dandelions Therapeutics Inc also referred to as Dandelion Science is a biotechnology company focused on developing programmable therapeutics for neuropsychiatric and neurological disorders. In August 2022, Dandelions Therapeutics Inc raised seed funding from SOSV. The company leverages artificial intelligence and machine learning to create therapies that target neural data pathways, aiming to revolutionize how brain disorders are treated.
Current Investors
SOSV
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Medical Software, Analytics & Performance Software
Verticals
Artificial Intelligence, Artificial Intelligence, HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.